| 11 Juin 2014
On 26 May 2014, the National IHR Focal Point of Iran reported to WHO the  first  2 laboratory confirmed cases of infection with Middle East  Respiratory Syndrome Coronavirus (MERS-CoV). The two patients are  sisters and residents of Kerman Province.
 The following details were provided to WHO:
 
 • A 52 year-old woman who became ill on 11 May and was admitted to the  hospital on the same day.  The patient is currently in a critical  condition. She is known to have an underlying medical condition.  The  patient did not have a history of travel.  She however, had a history of  close contact with a woman who had an Influenza Like Illness (ILI) and  had travelled to Saudi Arabia to perform Umra. The patient had no  history of contact with animals and no history of consumption of raw  camel products in the 14 days prior to becoming ill.
 
 • A 50 year-old woman who became ill on 11 May and was  admitted to a  hospital  on 17 May.  She is currently in a stable condition. The  patient is known to have an underlying medical condition.  She does not  have a history of travel. She is reported to have had close contact with  her sister, abovementioned 52 year-old patient. The patient had no  history of contact with animals and no history of consumption of raw  camel products in the 14 days prior to becoming ill.
 
 All close contacts of the abovementioned cases, including family  members, other patients in the hospital, and health care workers are  currently under investigation by the provincial health authorities and  the Iranian Centre for Disease Control. Some control measures have been  put in place at the hospital where the two cases are hospitalized.  Relevant information and instructions have been disseminated to  relatives, airport personnel, pilgrims returning from Umra and  travellers.
 
 Globally, 683 laboratory-confirmed cases of infection with MERS-CoV  including 204 related deaths have officially been reported to WHO. This  global total includes all of the cases reported in this update, plus 44  laboratory-confirmed cases officially reported to WHO by Saudi Arabia  between 19 May and 2 June. WHO is working closely with Saudi Arabia for  additional information on these cases and will provide further updates  as soon as possible.
 
 WHO advice
 Based on the current situation and available information, WHO encourages  all Member States to continue their surveillance for acute respiratory  infections and to carefully review any unusual patterns.
 
 Infection prevention and control measures are critical to prevent the  possible spread of MERS-CoV in health care facilities.  It is not always  possible to identify patients with MERS-CoV early because like other  respiratory infections, the early symptoms of MERS-CoV are  non-specific.  Therefore, health-care workers should always apply  standard precautions consistently with all patients, regardless of their  diagnosis.   Droplet precautions should be added to the standard  precautions when providing care to patients with symptoms of acute  respiratory infection; contact precautions and eye protection should be  added when caring for probable or confirmed cases of MERS-CoV infection;  airborne precautions should be applied when performing aerosol  generating procedures.
 
 Until more is understood about MERS-CoV, people with diabetes, renal  failure, chronic lung disease, and immunocompromised persons are  considered to be at high risk of severe disease from MERS‐CoV infection.  Therefore, these people should avoid close contact with animals,  particularly camels, when visiting farms,  markets, or barn areas  where  the virus is known to be potentially circulating.  General hygiene  measures such as regular hand washing before and after touching animals  and avoiding contact with sick animals, should be adhered to. 
 
 Food hygiene practices should be observed. People should avoid drinking  raw camel milk or camel urine, or eating meat that has not been properly  cooked.
 
 WHO does not advise special screening at points of entry with regard to  this event nor does it currently recommend the application of any travel  or trade restrictions.
 
 For further information: 
http://who.int/csr/disease/coronavirus_infections/faq/en/
 
http://www.who.int/ith/updates/20140603/en/
 
http://who.int/csr/bioriskreduction/infection_control/publication/en/